RVMDW
Revolution Medicines, Inc. WarrantstockNASDAQWarrant
Market OpenNov 18, 2026 3:59:30 PM EST
6.25USD-4.580%(-0.30)22,068
RVMDW Financials
In Q3 FY 2026 (ended ), Revolution Medicines, Inc. Warrant (RVMDW) reported revenue of $197.56M, net income of −$407.46M, operating cash flow of −$415.65M, and assets of $4.3B (filed ).
Loading financial statements…